|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
6992R-2 |
| Symbol |
GluRIIA |
Full Name |
Glutamate receptor IIA |
| CG No |
CG6992 |
Old CG No |
CG6992 |
| Synonyms |
GluRIIa, DGluR-IIA, D-GluRIIA, dglurIIA, GluR2a, dglur-IIA, dGluRIIA, GluRII-A, DGluRIIA, GluRII, GlurIIA, DgluRII, glurIIA, GluR, DGluR2a, unnamed, DGluR-II, dGluRII, Glu-RII, CG6992, Glu-RIIA, GluRIIA |
| Accession No (Link to NCBI) |
NM_078760.2 |
| Inserted Chr. |
lll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
semi-lethal |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K.
A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction.
PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgTGGAGGGGATTATAGCCCTTG |
| Primer Seq. 3' |
aatctagaggtaccGTTCATCAGATCCTGCAGGCG |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 TGGAGGGGAT TATAGCCCTT GGTgGNGNCG ATCGCAATGA AATCACAGTG GGTGCCATTT
0061 TCTACGAGAA CGAGAAGGAG ATCGAGCTCA GCTTCGATCA GGCCTTTCGC GAGGTCAACA
0121 ATATGAAGTT CTCGGAGCTG CGATTCGTGA CCATCAAACG CTATATGCCC ACCAACGACA
0181 GTTTCCTTTT GCAGCAGATT ACATGTGAAC TGATTTCCAA TGGCGTTGCG GCNTATTTTC
0241 GGACCAAGTT CAAAGGCAGC CAGTGATATT GTTGCGCAAA TCGCGAACGC GACCGGCATT
0301 CCACACATTG AGTACGATTT GAAGCTGGAG GCCACGCGTC AGGAGCAGCT CAACCACCAG
0361 ATGTCCATCA ATGTGGCACC CTCCTTGTCA GTACTCTCGC GTGCCTACTT CGAGATCATC
0421 AAATCCAACT ATGAGTGGCG CACCTTCACT CTGATCTATG AGACTCCGGA gGGCCTGGCG
0481 CGCCTGCAGG ATCTGATGAA C |
| in silico PCR Fragment |
0001 TGGAGGGGAT TATAGCCCTT GGTGGCGACG ATCGCAATGA AATCACAGTG GGTGCCATTT
0061 TCTACGAGAA CGAGAAGGAG ATCGAGCTCA GCTTCGATCA GGCCTTTCGC GAGGTCAACA
0121 ATATGAAGTT CTCGGAGCTG CGATTCGTGA CCATCAAACG CTATATGCCC ACCAACGACA
0181 GTTTCCTTTT GCAGCAGATT ACATGTGAAC TGATTTCCAA TGGCGTTGCG GC-TATTTTC
0241 GGACCAAGTT CAAAGGCAGC CAGTGATATT GTTGCGCAAA TCGCGAACGC GACCGGCATT
0301 CCACACATTG AGTACGATTT GAAGCTGGAG GCCACGCGTC AGGAGCAGCT CAACCACCAG
0361 ATGTCCATCA ATGTGGCACC CTCCTTGTCA GTACTCTCGC GTGCCTACTT CGAGATCATC
0421 AAATCCAACT ATGAGTGGCG CACCTTCACT CTGATCTATG AGACTCCGGA GGGCCTGGCG
0481 CGCCTGCAGG ATCTGATGAA C |
| Assemble Data |
6992R-2.IR_full 1 TGGAGGGGATTATAGCCCTTGGTGGNGNCGATCGCAATGAAATCACAGTGGGTGCCATTT 60
||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||
6992R-2.in silico 1 TGGAGGGGATTATAGCCCTTGGTGGCGACGATCGCAATGAAATCACAGTGGGTGCCATTT 60
6992R-2.IR_full 61 TCTACGAGAACGAGAAGGAGATCGAGCTCAGCTTCGATCAGGCCTTTCGCGAGGTCAACA 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 61 TCTACGAGAACGAGAAGGAGATCGAGCTCAGCTTCGATCAGGCCTTTCGCGAGGTCAACA 120
6992R-2.IR_full 121 ATATGAAGTTCTCGGAGCTGCGATTCGTGACCATCAAACGCTATATGCCCACCAACGACA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 121 ATATGAAGTTCTCGGAGCTGCGATTCGTGACCATCAAACGCTATATGCCCACCAACGACA 180
6992R-2.IR_full 181 GTTTCCTTTTGCAGCAGATTACATGTGAACTGATTTCCAATGGCGTTGCGGCNTATTTTC 240
|||||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
6992R-2.in silico 181 GTTTCCTTTTGCAGCAGATTACATGTGAACTGATTTCCAATGGCGTTGCGGC-TATTTTC 240
6992R-2.IR_full 241 GGACCAAGTTCAAAGGCAGCCAGTGATATTGTTGCGCAAATCGCGAACGCGACCGGCATT 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 241 GGACCAAGTTCAAAGGCAGCCAGTGATATTGTTGCGCAAATCGCGAACGCGACCGGCATT 300
6992R-2.IR_full 301 CCACACATTGAGTACGATTTGAAGCTGGAGGCCACGCGTCAGGAGCAGCTCAACCACCAG 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 301 CCACACATTGAGTACGATTTGAAGCTGGAGGCCACGCGTCAGGAGCAGCTCAACCACCAG 360
6992R-2.IR_full 361 ATGTCCATCAATGTGGCACCCTCCTTGTCAGTACTCTCGCGTGCCTACTTCGAGATCATC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 361 ATGTCCATCAATGTGGCACCCTCCTTGTCAGTACTCTCGCGTGCCTACTTCGAGATCATC 420
6992R-2.IR_full 421 AAATCCAACTATGAGTGGCGCACCTTCACTCTGATCTATGAGACTCCGGAGGGCCTGGCG 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6992R-2.in silico 421 AAATCCAACTATGAGTGGCGCACCTTCACTCTGATCTATGAGACTCCGGAGGGCCTGGCG 480
6992R-2.IR_full 481 CGCCTGCAGGATCTGATGAAC 501
|||||||||||||||||||||
6992R-2.in silico 481 CGCCTGCAGGATCTGATGAAC 501
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_078760.2 |
CG6992-RI (GluRIIA), mRNA |
| 2.28 |
11 |
6 |
13 |
15 |
NM_164399.1 |
CG4226-RB, transcript variant B (GluRIIC), mRNA |
| 2.28 |
11 |
6 |
13 |
15 |
NM_134713.2 |
CG4226-RA, transcript variant A (GluRIIC), mRNA |
| 1.24 |
6 |
6 |
4 |
11 |
NM_078761.3 |
CG7234-RI (GluRIIB), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032073.1 |
CG6713-RB, transcript variant B (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032072.1 |
CG6713-RC, transcript variant C (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032070.1 |
CG6713-RE, transcript variant E (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032067.1 |
CG6713-RH, transcript variant H (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032075.1 |
CG6713-RI, transcript variant I (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032074.1 |
CG6713-RJ, transcript variant J (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032069.1 |
CG6713-RF, transcript variant F (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032068.1 |
CG6713-RG, transcript variant G (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_078817.3 |
CG6713-RA, transcript variant A (Nos), mRNA |
| 1.03 |
5 |
4 |
3 |
3 |
NM_001032071.1 |
CG6713-RD, transcript variant D (Nos), mRNA |
| 0 |
0 |
5 |
6 |
3 |
NM_139583.2 |
CG10863-RA (CG10863), mRNA |
| 0 |
0 |
3 |
3 |
4 |
NM_169092.1 |
CG1109-RB, transcript variant B (CG1109), mRNA |
| 0 |
0 |
3 |
3 |
4 |
NM_169091.1 |
CG1109-RA, transcript variant A (CG1109), mRNA |
| 0 |
0 |
2 |
3 |
7 |
NM_132278.2 |
CG12075-RA, transcript variant A (CG12075), mRNA |
| 0 |
0 |
2 |
3 |
7 |
NM_206663.1 |
CG12075-RB, transcript variant B (CG12075), mRNA |
| 0 |
0 |
2 |
3 |
6 |
NM_170035.1 |
CG4917-RB, transcript variant B (wfs1), mRNA |
| 0 |
0 |
2 |
3 |
6 |
NM_142822.1 |
CG4917-RA, transcript variant A (wfs1), mRNA |
| 0 |
0 |
2 |
2 |
4 |
NM_079702.2 |
CG3637-RA (Cortactin), mRNA |
| 0 |
0 |
1 |
6 |
3 |
NM_057466.2 |
CG8896-RA (18w), mRNA |
| 0 |
0 |
1 |
4 |
5 |
NM_136154.1 |
CG10631-RA (CG10631), mRNA |
| 0 |
0 |
1 |
4 |
2 |
NM_001015363.1 |
CG40064-PA (CG40064), mRNA |
| 0 |
0 |
1 |
3 |
6 |
NM_001032051.1 |
CG33715-RD, transcript variant D (Msp-300), mRNA |
| 0 |
0 |
1 |
3 |
5 |
NM_132543.1 |
CG10362-RA (CG10362), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_168670.1 |
CG32158-RB, transcript variant B (CG32158), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_001032053.1 |
CG33715-RB, transcript variant B (Msp-300), mRNA |
| 0 |
0 |
1 |
3 |
2 |
NM_170029.1 |
CG31161-RA (CG31161), mRNA |
|
|
|
